Biden Getting Pfizer COVID-19 Booster Shot

WASHINGTON — President Joe Biden will receive his COVID-19 booster shot on Monday, days after federal regulators recommended a third dose of the Pfizer vaccine for Americans age 65 or older and approved them for others with preexisting medical conditions and high-risk work environments.

The White House said Biden, 78, would deliver remarks and receive the additional dose at 1 p.m. Monday.

Biden got his first shot on Dec. 21 and his second dose three weeks later, on Jan. 11, along with his wife, Jill Biden. It was not immediately clear whether the first lady would also receive the booster dose on Monday.

Speaking on Friday after the Centers for Disease Control and Prevention and the Food and Drug Administration authorized the Pfizer booster, Biden told reporters, “I’ll be getting my booster shot. It’s hard to acknowledge I’m over 65, but I’ll be getting my booster shot. ”

Vice President Kamala Harris, 56, received the Moderna vaccine, for which federal regulators have not yet authorized boosters — but they are expected to in the coming weeks.

Post source: Time

Soundhealthandlastingwealth.com offer the most up-to-date information from top experts, new research, and health agencies, but our content is not meant to be a substitute for professional guidance. When it comes to the medication you're taking or any other health questions you have, always consult your healthcare provider directly.
You May Also Like

Early-onset heart failure significantly elevates the risk of all-cause mortality.

Early-onset heart failure significantly elevates the risk of all-cause mortality. Research has…

Video of how Dr Akunyili struggled for his life moments after he was shot

Video of how Dr Akunyili struggled for his life moments after he…

San Francisco to force five-year-olds to show proof of vaccination to enter indoor venues

San Francisco: Children aged five to 11 will be forced to prove…

People under 21 might be more vulnerable to Indian Covid variant, expert fears

People under 21 might be more vulnerable to Indian Covid variant, expert…